These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 4771904)

  • 1. Differential study of 2 long-acting neuroleptics, fluphenazine enanthate and pipothiazine undecylenate.
    Gayral LF; Escande MM; Fournie HC; Huron RJ
    Therapie; 1973; 28(3):611-25. PubMed ID: 4771904
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J; Woggon B
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolonged action neuroleptics (review of the foreign literature)].
    Obukhov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
    Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
    J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trial of delayed-action neuroleptics in the treatment of acute psychotic conditions].
    Gayral L; Escande M; Fournié H; Perretti A
    Ann Med Psychol (Paris); 1972 Mar; 1(3):381-94. PubMed ID: 5053751
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluspirilene and pipothiazine undecylenate, two long-acting injectable neuroleptics. A double-blind controlled trial in residual schizophrenia.
    Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1972; 75(2):117-27. PubMed ID: 5030483
    [No Abstract]   [Full Text] [Related]  

  • 7. [Importance of delayed-action compounds for management of neuroleptic treatments. (Apropos of fluphenazine enanthate)].
    Delay J; Deniker P; Perier M; Dalle B
    Presse Med (1893); 1967 May; 75(24):1243-6. PubMed ID: 6024177
    [No Abstract]   [Full Text] [Related]  

  • 8. [Differential indication for the use of neuroleptics].
    Vinar O
    Act Nerv Super (Praha); 1970 Jan; 12(1):1-11. PubMed ID: 4907389
    [No Abstract]   [Full Text] [Related]  

  • 9. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F
    Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
    [No Abstract]   [Full Text] [Related]  

  • 10. [Importance of delayed-action neuroleptics].
    Fouks ; Houssait ; Mathis ; Gay M; Ferragu ; Gilbert
    Ann Med Psychol (Paris); 1969 May; 127(5):772-8. PubMed ID: 5397523
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of delayed-action neuroleptics].
    Fouks ; Houssait ; Mathis ; Gay M; Ferragu ; Gilbert
    Ann Med Psychol (Paris); 1969 May; 1(5):772-8. PubMed ID: 5398062
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-acting neuroleptic preparations and their use in mental disorders].
    Vovin RIa; Vovina EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):920-4. PubMed ID: 5050052
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and ambulatory experiences with fluphenazine decanoate lyogen depot in prolonged therapy of psychiatric disorders].
    Moldenhauer B
    Med Welt; 1970 Jun; 25():1150-4. PubMed ID: 5512636
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of new drug treatments in child psychiatry (long-acting neuroleptics, antidepressive agents and lithium)].
    Dugas M; Velin J; Guériot C; Frohwirth C
    Cah Med; 1973 Sep; 14(9):711-6. PubMed ID: 4779496
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.
    Malm U; Perris C; Rapp W; Wedrén G
    Acta Psychiatr Scand Suppl; 1974; 249():94-116. PubMed ID: 4608506
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychiatric pharmacotherapy and the schizophrenic defect.
    Molcan J; Floreánová L; Novotný V; Polák L; Rakús A; Motýlová A
    Act Nerv Super (Praha); 1973 May; 15(2):91. PubMed ID: 4148088
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-action neuroleptic agents (delayed-action neuroleptics)].
    Ginestet D; Péron-Magnan P
    Rev Prat; 1972 Apr; 22(12):1941-53. PubMed ID: 4675045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Considerations on the use of long-acting neuroleptics in a mental health center].
    Carotti P; Merli R
    Minerva Med; 1986 Sep; 77(34-35):1577-83. PubMed ID: 2876402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Initial results of clinical trial of a new long-acting neuroleptic agent: Fluspirelene].
    Ciccarelli G; Nosè F
    Minerva Med; 1971 Dec; 62(98):4922-7. PubMed ID: 5141918
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in clinical effects of three phenothiazines in "acute" schizophrenia.
    Dis Nerv Syst; 1967 Jun; 28(6):369-83. PubMed ID: 5342391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.